Schizophrenia: all 3,539 studies

Page 9 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• TDCS for Auditory Hallucinations in SchizophreniaCompletedNCT01898299Not applicableResults posted
• An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)CompletedNCT01895452Phase 3Results posted
• An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of SchizophreniaTerminatedNCT01894984Results posted
• Safety and Tolerability of BI 409306 in Patients With SchizophreniaCompletedNCT01892384Phase 1Results posted
• Evaluating Two Types of Cognitive Training in Veterans With SchizophreniaCompletedNCT01891721Not applicableResults posted
• Get Moving and Get Well - Pilot StudyCompletedNCT01884025Not applicableResults posted
• Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy ParticipantsCompletedNCT01879722Phase 1Results posted
• The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With SchizophreniaTerminatedNCT01874756Phase 2Results posted
• A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM DepotCompletedNCT01870999Phase 1Results posted
• Naltrexone for Antipsychotic-Induced Weight GainCompletedNCT01866098Not applicableResults posted
• An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersCompletedNCT01855074Phase 4Results posted
• PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With SchizophreniaCompletedNCT01854944Phase 1Results posted
• The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological PhenotypesTerminatedNCT01832766Phase 1/2Results posted
• A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With SchizophreniaCompletedNCT01829048Phase 1Results posted
• Lurasidone Low-Dose - High-Dose Study StudyCompletedNCT01821378Phase 3Results posted
• Brexpiprazole in Patients With SchizophreniaCompletedNCT01810783Phase 3Results posted
• Brexpiprazole in Patients With Acute SchizophreniaCompletedNCT01810380Phase 3Results posted
• Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry StudyCompletedNCT01804257Not applicableResults posted
• Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With SchizophreniaCompletedNCT01795547Phase 3Results posted
• Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for SchizophreniaCompletedNCT01793935Not applicableResults posted
• Omega-3 Dietary Supplements in SchizophreniaCompletedNCT01786239Not applicableResults posted
• Fingolimod in Schizophrenia PatientsCompletedNCT01779700Phase 2Results posted
• Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTerminatedNCT01760993Phase 3Results posted
• SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTerminatedNCT01760889Phase 3Results posted
• Oxytocin and CBSST for People With SchizophreniaCompletedNCT01752712Not applicableResults posted
• Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of SchizophreniaTerminatedNCT01738698Phase 3Results posted
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2Results posted
• Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With SchizophreniaCompletedNCT01726335Phase 4Results posted
• Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With SchizophreniaCompletedNCT01724359Phase 4Results posted
• Kuvan in People With Schizophrenia and Schizoaffective DisorderCompletedNCT01706965Phase 1/2Results posted
• An Open-Label Trial of Tocilizumab in SchizophreniaCompletedNCT01696929Phase 1Results posted
• NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)CompletedNCT01688037Phase 2Results posted
• Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaCompletedNCT01683058Phase 3Results posted
• Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/EfficacyCompletedNCT01677377Phase 2Results posted
• Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With SchizophreniaCompletedNCT01668797Phase 3Results posted
• PACT for Individuals With Serious Mental IllnessCompletedNCT01668355Not applicableResults posted
• Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With SchizophreniaCompletedNCT01663532Phase 3Results posted
• Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With SchizophreniaCompletedNCT01662648Phase 3Results posted
• An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With SchizophreniaCompletedNCT01662310Phase 3Results posted
• Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective DisorderCompletedNCT01658150Not applicableResults posted
• A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mgCompletedNCT01654601Phase 1Results posted
• Multicenter, Open-label, Safety and Tolerability StudyCompletedNCT01649557Phase 2Results posted
• An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With SchizophreniaCompletedNCT01646827Phase 1Results posted
• Effects of Eszopiclone on Sleep and Memory in SchizophreniaCompletedNCT01641900Not applicableResults posted
• Clozapine for Cannabis Use in SchizophreniaCompletedNCT01639872Phase 4Results posted
• A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs SchizophreniaCompletedNCT01626885Phase 2/3Results posted
• Long-Term Study of MP-214 in Patients With SchizophreniaCompletedNCT01626872Phase 2/3Results posted
• A Pharmacokinetic Study of MP-214 in Patients With SchizophreniaCompletedNCT01626859Phase 2/3Results posted
• A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)CompletedNCT01626456Phase 3Results posted
• A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly SchizophreniaCompletedNCT01625897Phase 2/3Results posted
• Safety and Efficacy of MP-214 in Patients With SchizophreniaCompletedNCT01625000Phase 2/3Results posted
• Antipsychotic Effects of OxytocinTerminatedNCT01621737Not applicableResults posted
• Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in SchizophreniaCompletedNCT01620086Not applicableResults posted
• Lurasidone Pediatric Pharmacokinetics StudyCompletedNCT01620060Phase 1Results posted
• A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)CompletedNCT01617187Phase 3Results posted
• Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT01614912Phase 3Results posted
• A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT01614899Phase 3Results posted
• Effects of Intranasal Oxytocin on Satiety Signaling in People With SchizophreniaCompletedNCT01614093Phase 4Results posted
• Acute Glycine Pharmacodynamic StudyCompletedNCT01610011Not applicableResults posted
• A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With SchizophreniaCompletedNCT01606436Phase 1Results posted
• A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With SchizophreniaCompletedNCT01606254Phase 2Results posted
• A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With SchizophreniaCompletedNCT01606228Phase 3Results posted
• Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With SchizophreniaTerminatedNCT01598896Phase 2/3Results posted
• Psychosis: Early Detection, Intervention and PreventionCompletedNCT01597141Not applicableResults posted
• Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in SchizophreniaTerminatedNCT01595503Not applicableResults posted
• Behavior During Experimentally Induced PainCompletedNCT01594528Not applicableResults posted
• Salsalate as an Adjunctive Treatment for Patients With SchizophreniaCompletedNCT01578486Phase 4Results posted
• Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)CompletedNCT01577186Phase 4Results posted
• A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With SchizophreniaCompletedNCT01577160Phase 4Results posted
• Past Pain Experience and Perception of Experimental PainCompletedNCT01575912Results posted
• High Dose Lurasidone for Patients With Treatment Resistant SchizophreniaCompletedNCT01569659Phase 4Results posted
• Oxytocin as Adjunctive Treatment of SchizophreniaCompletedNCT01568528Phase 2Results posted
• Contingency Management of Alcohol Abuse in the Severely Mentally ILLCompletedNCT01567943Not applicableResults posted
• A Twelve Week, Open Label Extension Study in Patients With SchizophreniaCompletedNCT01566162Phase 3Results posted
• A Long-Term Study of JNS007ER in Patients With SchizophreniaCompletedNCT01561898Phase 3Results posted
• Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With SchizophreniaCompletedNCT01556763Phase 1Results posted
• Biomarker Strategies for Medication-Enhanced Cognitive Training in SchizophreniaCompletedNCT01555697Phase 1/2Results posted
• Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than AripiprazoleCompletedNCT01552772Phase 1Results posted
• Therapeutic Efficacy of Transcranial Magnetic Stimulation in SchizophreniaCompletedNCT01551979Not applicableResults posted
• Once-Daily Asenapine for SchizophreniaCompletedNCT01549041Phase 4Results posted
• PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)CompletedNCT01542229Not applicableResults posted
• A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With SchizophreniaCompletedNCT01541371Phase 3Results posted
• A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With SchizophreniaCompletedNCT01529515Phase 3Results posted
• Cognitive Training for Patients With SchizophreniaCompletedNCT01521026Not applicableResults posted
• Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With RisperidoneCompletedNCT01516424Phase 3Results posted
• Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With SchizophreniaCompletedNCT01515423Phase 3Results posted
• Anti-Inflammatory Treatment of SchizophreniaCompletedNCT01514682Not applicableResults posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleTerminatedNCT01509053Phase 3Results posted
• Study of a Novel Antipsychotic ITI-007 in SchizophreniaCompletedNCT01499563Phase 2Results posted
• Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With OlanzapineTerminatedNCT01491490Phase 2Results posted
• Life Goals Collaborative Care to Improve Health Outcomes in Mental DisordersCompletedNCT01487668Not applicableResults posted
• Lurasidone Extended Use StudyCompletedNCT01485640Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With SchizophreniaCompletedNCT01469039Phase 3Results posted
• Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With SchizophreniaCompletedNCT01457339Phase 1Results posted
• A Long-term Trial of OPC-34712 in Patients With SchizophreniaCompletedNCT01456897Phase 3Results posted
• A Physical Dependence Study in SchizophreniaCompletedNCT01452919Phase 3Results posted
• A Dose-finding Trial of OPC-34712 in Patients With SchizophreniaCompletedNCT01451164Phase 2/3Results posted
• PEARL Schizophrenia MaintenanceCompletedNCT01435928Phase 3Results posted
• Adjunctive Minocycline in Clozapine Treated Schizophrenia PatientsCompletedNCT01433055Not applicableResults posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleCompletedNCT01432444Phase 3Results posted

← Schizophrenia overview